Should I stop Evenity (romosozumab) for my temporomandibular joint symptoms?

Should You Stop Evenity for TMJ Symptoms?

No, you should not stop Evenity (romosozumab) for temporomandibular joint (TMJ) symptoms alone unless you have developed medication-related osteonecrosis of the jaw (MRONJ).

Understanding the Context

TMJ symptoms (pain, clicking, limited jaw movement) are not the same as MRONJ, which is a serious complication involving exposed necrotic bone in the jaw. The distinction is critical:

• TMJ disorder: Joint pain, muscle dysfunction, clicking—does not require stopping Evenity
• MRONJ: Exposed bone in the jaw that doesn't heal for >8 weeks, often with pain, infection, or fistula formation—may warrant consideration of drug discontinuation

When MRONJ is NOT Present

If you simply have TMJ symptoms without exposed bone or signs of jaw bone necrosis, continue Evenity as prescribed. TMJ disorders are common (affecting up to 12% of the population) and are managed with conservative therapies including NSAIDs, muscle relaxants, physical therapy, and potentially injections 1. These symptoms do not represent a contraindication to continuing osteoporosis treatment.

When MRONJ IS Diagnosed

If you develop actual MRONJ while on Evenity, the evidence for stopping the medication is weak and conflicting 2. According to the 2019 MASCC/ISOO/ASCO guidelines:

• There is insufficient evidence to support or refute discontinuation of bone-modifying agents (BMAs) when MRONJ is diagnosed 2
• The decision to defer Evenity should be made by your treating physician in conjunction with your oral health provider 2
• For medications like romosozumab with shorter half-lives compared to bisphosphonates, temporary discontinuation may enhance MRONJ resolution, but this must be weighed against the risk of fractures 2

MRONJ Management Strategy (If Diagnosed)

The treatment approach depends on staging 2:

Stage 1 (exposed bone, no symptoms):

• Antibacterial mouth rinse
• Close monitoring every 8 weeks
• Good oral hygiene
• Drug discontinuation is optional, not mandatory

Stage 2 (exposed bone with infection/pain):

• Oral antibiotics and antibacterial rinse
• Pain control
• Limited debridement
• Drug discontinuation remains discretionary

Stage 3 (extensive bone involvement, pathologic fracture):

• Surgical debridement or resection
• Antibiotics and pain management
• Drug discontinuation should be discussed with your oncologist/prescriber

Critical Warnings About Evenity

Before any decision about stopping Evenity, consider these FDA-mandated warnings 3:

1. Cardiovascular risk: Evenity carries an increased risk of heart attack, stroke, and cardiovascular death—especially if you've had these events in the past year 3, 4
2. Osteonecrosis of the jaw: The FDA label explicitly warns about severe jaw bone problems and recommends dental examination before starting treatment 3
3. Limited treatment duration: Evenity is only given for 12 monthly doses because its bone-forming effect wanes after that 5

Practical Algorithm

Step 1: Determine if you have true MRONJ or just TMJ symptoms

• Do you have exposed bone in your mouth visible for >8 weeks?
• Do you have a non-healing extraction site or spontaneous bone exposure?
• NO → Continue Evenity, treat TMJ conservatively
• YES → Proceed to Step 2

Step 2: If MRONJ is confirmed, assess staging and cardiovascular risk

• Communicate with both your prescribing physician and oral surgeon 2
• Consider that stopping Evenity may not improve MRONJ outcomes 2
• Weigh fracture risk (which is high if you're on Evenity) against potential MRONJ benefit from stopping

Step 3: Preventive dental care is mandatory

• Complete any needed dental work before continuing Evenity 3
• Maintain excellent oral hygiene throughout treatment
• Inform your dentist you're receiving Evenity before any dental procedures 3

Common Pitfalls to Avoid

1. Don't confuse TMJ disorder with MRONJ: Most jaw pain is NOT osteonecrosis
2. Don't stop Evenity without consulting your prescriber: The fracture risk from untreated osteoporosis may exceed the MRONJ risk
3. Don't assume stopping the drug will cure MRONJ: Evidence shows mixed results at best 2
4. Don't ignore cardiovascular history: If you've had a recent MI or stroke, Evenity may not be appropriate regardless of jaw symptoms 3, 4

Bottom Line

For simple TMJ symptoms: Continue Evenity and manage TMJ conservatively. For confirmed MRONJ: This is a shared decision between you, your prescribing physician, and your oral surgeon, recognizing that stopping Evenity has insufficient evidence for benefit and carries fracture risk 2. The most important action is proper dental evaluation and preventive care before and during Evenity treatment 3.